B Cell News and Research

RSS

Uncontrolled growth as a cancer cell's weakness

Growth is a fundamental biological process and a prerequisite for living organisms to develop and reproduce. The processes of cell growth (i.e. the production of new biomass) and of cell division must be coordinated with each other.

17 Nov 2023

Green tea-silver nanoparticles: A promising weapon against superbugs

Once upon a time, people believed to be invincible against bacterial diseases, thanks to the antibiotics. Does this sound like a fairy tale? By all means! Nothing could be further from the truth.

17 Nov 2023

Pioneering collaboration aims to fight against pancreatic cancer

In a significant global initiative coinciding with World Pancreatic Cancer Day on Thursday, November 16, the soon-to-launch Botton-Champalimaud Pancreatic Cancer Centre in Portugal, in partnership with the Jreissati Pancreatic Centre at Epworth in Australia and the Cancer Research UK Cambridge Centre - Pancreatic Cancer Programme in the United Kingdom, announces a pioneering collaboration.

17 Nov 2023

Immunogenicity of insect-specific Zika virus-vectorized vaccine candidates

The immunogenicity, safety, and effectiveness of ARPV/ZIKV a chimeric insect-specific flavivirus (ISFV)-Zika vaccine.

17 Nov 2023

Most states ban shackling pregnant women in custody, yet many report being restrained

Ashley Denney was about seven months pregnant in 2022 when police handcuffed her during an arrest in Carroll County, Georgia.

17 Nov 2023

Promising new cancer therapy appears to be extremely potent against tuberculosis

A promising new cancer therapy also appears extremely potent against one of the world's most devastating infectious diseases: tuberculosis (TB).

16 Nov 2023

Scientists uncover "genomic tug of war" that influences chemotherapy's effectiveness

Some patients with myelodysplastic syndromes, like acute myeloid leukemia, benefit from a chemotherapy drug called decitabine that stunts cancer growth. But many others are resistant to decatibine's effects or become resistant over time.

16 Nov 2023

Coffee and COVID: Study finds coffee inhibits SARS-CoV-2, offers new dietary defense strategy

Study discovers that coffee, especially its bioactive compounds like chlorogenic acids, can inhibit SARS-CoV-2 entry and reduce ACE2 and TMPRSS2 levels, indicating that coffee intake might be a potential dietary strategy for COVID-19 prevention.

16 Nov 2023

New insights into how cells maintain their identity over generations

Every cell in the human body contains the same genetic instructions, encoded in its DNA. However, out of about 30,000 genes, each cell expresses only those genes that it needs to become a nerve cell, immune cell, or any of the other hundreds of cell types in the body.

16 Nov 2023

Diabetes linked to higher colorectal cancer risk in low-income African-Americans, study shows

JAMA Network Open study finds that diabetes increases colorectal cancer risk among low-income African-American individuals, with stronger associations observed in women, smokers, and those recently diagnosed, suggesting that glycemic control and colonoscopy screenings could mitigate risk.

16 Nov 2023

B-BiTE modality enhances anti-myeloma effects of clinically available antibodies

Multiple myeloma still appears to be an incurable hematological malignancy. One of the reasons is that myeloma cells can be heterogenous and acquire resistance after anti-myeloma treatment.

16 Nov 2023

Long-term monitoring of gene therapy patients crucial for safety, study says

Medical research has shown promising results regarding the potential of gene therapy to cure genetic conditions such as sickle cell disease and the findings of this study, published in Nature Medicine, offer important new insights into processes happening in the body after treatment.

16 Nov 2023

Gene splicing determines CD20 levels and response to monoclonal antibody therapy

Immunotherapies that target the CD20 antigen have revolutionized how patients with a variety of blood cancers and hematologic disorders have been treated.

16 Nov 2023

TACTIC project aims to uncover genetic causes of cancer and develop targeted therapies

Investigating the genetic causes of cancer and fighting them with new drugs: To this end, German Cancer Aid is funding the TACTIC project until 2028 with 11.8 million euros.

16 Nov 2023

Exploring the dual role of nirmatrelvir and bisphosphonates in COVID-19 treatment and immunity

Review examines nirmatrelvir and bisphosphonates in treating COVID-19, revealing their impact on SARS-CoV-2-specific adaptive immunity and potential to mitigate severe infections, highlighting the need for balanced long-term immunity management.

16 Nov 2023

Molecular trap offers hope for ALS treatment

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects neurons in the brain and spinal cord causing loss of muscle control.

16 Nov 2023

Intestinal hormones hold promise for halting liver scarring

Hormone therapy may be associated with menopause and fertility treatment, but now an SDU-led research team reports that certain intestinal hormones seem to have a beneficial effect on the processes behind the formation of scar tissue in the liver (liver fibrosis).

16 Nov 2023

AI model predicts patient outcomes across multiple cancer types

Investigators from the UCLA Health Jonsson Comprehensive Cancer Center have developed an artificial intelligence (AI) model based on epigenetic factors that is able to predict patient outcomes successfully across multiple cancer types.

16 Nov 2023

MaxCyte joins the Alliance for mRNA Medicines (AMM) as a founding member

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and innovative bioprocessing applications, today announced that it has joined the Alliance for mRNA Medicines (AMM), as a founding member.

From MaxCyte, Inc. 16 Nov 2023

Rare APOE3-R136S mutation offers protection against Alzheimer's disease pathologies in new study

The R136S genetic mutation protected against apolipoprotein E4 (APOE4)-induced late-onset Alzheimer’s disease (LOAD).

16 Nov 2023

B Cell News and Research

Uncontrolled growth as a cancer cell's weakness

Green tea-silver nanoparticles: A promising weapon against superbugs

Pioneering collaboration aims to fight against pancreatic cancer

Immunogenicity of insect-specific Zika virus-vectorized vaccine candidates

Most states ban shackling pregnant women in custody, yet many report being restrained

Promising new cancer therapy appears to be extremely potent against tuberculosis

Scientists uncover "genomic tug of war" that influences chemotherapy's effectiveness

Coffee and COVID: Study finds coffee inhibits SARS-CoV-2, offers new dietary defense strategy

New insights into how cells maintain their identity over generations

Diabetes linked to higher colorectal cancer risk in low-income African-Americans, study shows

B-BiTE modality enhances anti-myeloma effects of clinically available antibodies

Long-term monitoring of gene therapy patients crucial for safety, study says

Gene splicing determines CD20 levels and response to monoclonal antibody therapy

TACTIC project aims to uncover genetic causes of cancer and develop targeted therapies

Exploring the dual role of nirmatrelvir and bisphosphonates in COVID-19 treatment and immunity

Molecular trap offers hope for ALS treatment

Intestinal hormones hold promise for halting liver scarring

AI model predicts patient outcomes across multiple cancer types

MaxCyte joins the Alliance for mRNA Medicines (AMM) as a founding member

Rare APOE3-R136S mutation offers protection against Alzheimer's disease pathologies in new study

Industry focus eBook - Cell and gene therapy (2nd edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News